Kirkland James L, Stout Michael B, Sierra Felipe
Mayo Clinic Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota.
Division of Aging Biology, National Institute on Aging, National Institutes of Health, Bethesda, Maryland.
J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1407-1414. doi: 10.1093/gerona/glw086. Epub 2016 Aug 16.
Recently discovered interventions that target fundamental aging mechanisms have been shown to increase life span in mice and other species, and in some cases, these same manipulations have been shown to enhance health span and alleviate multiple age-related diseases and conditions. Aging is generally associated with decreases in resilience, the capacity to respond to or recover from clinically relevant stresses such as surgery, infections, or vascular events. We hypothesize that the age-related increase in susceptibility to those diseases and conditions is driven by or associated with the decrease in resilience. Thus, a test for resilience at middle age or even earlier could represent a surrogate approach to test the hypothesis that an intervention delays the process of aging itself. For this, animal models to test resilience accurately and predictably are needed. In addition, interventions that increase resilience might lead to treatments aimed at enhancing recovery following acute illnesses, or preventing poor outcomes from medical interventions in older, prefrail subjects. At a meeting of basic researchers and clinicians engaged in research on mechanisms of aging and care of the elderly, the merits and drawbacks of investigating effects of interventions on resilience in mice were considered. Available and potential stressors for assessing physiological resilience as well as the notion of developing a limited battery of such stressors and how to rank them were discussed. Relevant ranking parameters included value in assessing general health (as opposed to focusing on a single physiological system), ease of use, cost, reproducibility, clinical relevance, and feasibility of being repeated in the same animal longitudinally. During the discussions it became clear that, while this is an important area, very little is known or established. Much more research is needed in the near future to develop appropriate tests of resilience in animal models within an aging context. The preliminary set of tests ranked by the participants is discussed here, recognizing that this is a first attempt.
最近发现的针对基本衰老机制的干预措施已被证明可延长小鼠和其他物种的寿命,在某些情况下,同样的操作还被证明可延长健康寿命并缓解多种与年龄相关的疾病和状况。衰老通常与恢复力下降有关,恢复力是指对临床相关应激(如手术、感染或血管事件)做出反应或从中恢复的能力。我们假设,对这些疾病和状况易感性的年龄相关性增加是由恢复力下降所驱动或与之相关。因此,在中年甚至更早阶段进行恢复力测试可能是一种替代方法,用于检验干预措施延缓衰老进程这一假设。为此,需要能够准确且可预测地测试恢复力的动物模型。此外,提高恢复力的干预措施可能会带来旨在增强急性疾病后恢复能力的治疗方法,或预防老年体弱前期受试者医疗干预不良后果的治疗方法。在一次从事衰老机制研究和老年人护理研究的基础研究人员与临床医生会议上,讨论了研究干预措施对小鼠恢复力影响的优缺点。讨论了用于评估生理恢复力的现有和潜在应激源,以及开发一套有限的此类应激源并对其进行排序的概念。相关的排序参数包括评估总体健康状况的价值(与专注于单一生理系统相对)、易用性、成本、可重复性以及临床相关性,以及在同一只动物身上纵向重复测试的可行性。在讨论过程中很明显,虽然这是一个重要领域,但所知甚少或尚未确立。在不久的将来,需要进行更多研究,以在衰老背景下开发适合动物模型的恢复力测试方法。本文讨论了参与者初步排序的一组测试,认识到这只是首次尝试。